Unknown

Dataset Information

0

In Vitro and in Silico Analysis of α -Amylase Inhibitory Activity of Ethanolic Extract of Adhatoda vasica Leaves.


ABSTRACT:

Objective

Diabetic individuals have a higher probability of suffering from illness and death due to small blood vessel-related problems such as retinopathy, neuropathy, nephropathy, and stroke than other complications. There are many synthetic anti-diabetic agents available, but these can be expensive and have undesirable pathological effects. The enzyme α-amylase (hydrolase), catalyzes the hydrolysis of starch to maltose and glucose via the cleavage of α-1,4-glucosidic linkages. Diabetes mellitus patients may benefit from a therapeutic strategy that involves slowing the hydrolysis of starch by inhibiting the activity of α-amylase. Thus, looking for cost-effective, natural, and safe antidiabetic agents is essential. This study aims to screen phytoconstituents and evaluate the in-vitro and in-silico α-amylase inhibitory activity of the ethanolic extract of Adhatoda vasica leaves.

Methods

The extraction of Adhatoda vasica leaves was performed using ethanol via the Soxhlet extraction process. Different concentrations (100 μg/mL to 1000 μg/mL) of ethanolic extract, Acarbose, and Sitagliptin, were prepared and evaluated for α-amylase inhibitory activity using the spectrophotometric method. Molecular docking (AutodockVina 1.2.0) and toxicity profiling (SToPToX web server) studies were performed.

Results

The ethanolic extract of Adhatoda vasica leaves showed the highest percentage inhibition against α-amylase (56.763 ± 0.0035) at a concentration of 1000 μg/mL. The in-silico study supported this inhibitory activity. Vasicoline (C5) and Quercetin (C9), the active constitute of Adhatoda vasica, showed the best binding energies of -8.3 and -8.0 Kcal/mol, respectively against α-amylase enzyme (PDBID: 4W93). A toxicity study revealed the safety profile of the plant extract.

Conclusion

It was concluded that Adhatoda vasica leaves possess some bioactive compounds that are responsible for controlling blood glucose levels, and their identification, purification, and isolation may lead to the development of new therapeutic agents with fewer side effects than the available drugs.

SUBMITTER: Yadav CK 

PROVIDER: S-EPMC11365037 | biostudies-literature | 2024 Jan-Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

In Vitro and in Silico Analysis of α -Amylase Inhibitory Activity of Ethanolic Extract of <i>Adhatoda vasica</i> Leaves.

Yadav Chandrajeet K CK   Kc Sandhya S   Thapa Shankar S  

Global advances in integrative medicine and health 20240101


<h4>Objective</h4>Diabetic individuals have a higher probability of suffering from illness and death due to small blood vessel-related problems such as retinopathy, neuropathy, nephropathy, and stroke than other complications. There are many synthetic anti-diabetic agents available, but these can be expensive and have undesirable pathological effects. The enzyme α-amylase (hydrolase), catalyzes the hydrolysis of starch to maltose and glucose via the cleavage of α-1,4-glucosidic linkages. Diabete  ...[more]

Similar Datasets

| S-EPMC10099809 | biostudies-literature
| S-EPMC9921906 | biostudies-literature
| S-EPMC7016239 | biostudies-literature
| S-EPMC11783736 | biostudies-literature
| S-EPMC5511825 | biostudies-other
| S-EPMC5553334 | biostudies-literature
| S-EPMC5332274 | biostudies-literature
| S-EPMC8997748 | biostudies-literature
| S-EPMC9737760 | biostudies-literature
| S-EPMC9784833 | biostudies-literature